147 related articles for article (PubMed ID: 27699629)
1. Genetic Screening in Pheochromocytoma/Paraganglioma.
Liu P; Zu X; Liu L
Pathol Oncol Res; 2017 Jan; 23(1):217. PubMed ID: 27699629
[No Abstract] [Full Text] [Related]
2. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center.
Asban A; Kluijfhout WP; Drake FT; Beninato T; Wang E; Chomsky-Higgins K; Shen WT; Gosnell JE; Suh I; Duh QY
J Surg Oncol; 2018 May; 117(6):1217-1222. PubMed ID: 29315604
[TBL] [Abstract][Full Text] [Related]
3. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
[TBL] [Abstract][Full Text] [Related]
4. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
Vermalle M; Tabarin A; Castinetti F
Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
Benn DE; Richardson AL; Marsh DJ; Robinson BG
Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
[TBL] [Abstract][Full Text] [Related]
6. Phaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes.
Maher ER
Clin Med (Lond); 2014 Aug; 14(4):440-4. PubMed ID: 25099851
[No Abstract] [Full Text] [Related]
7. The pheochromocytoma and paraganglioma syndrome: founder effects and the PGL 1 syndrome.
Opocher G; Boaretto F; Pignataro V; Demattè S; Cecchini ME; Erlic Z; Schiavi F
Ann Endocrinol (Paris); 2009 Jun; 70(3):157-60. PubMed ID: 19286157
[No Abstract] [Full Text] [Related]
8. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
9. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
[TBL] [Abstract][Full Text] [Related]
10.
Evenepoel L; Helaers R; Vroonen L; Aydin S; Hamoir M; Maiter D; Vikkula M; Persu A
Endocr Relat Cancer; 2017 Aug; 24(8):L57-L61. PubMed ID: 28515046
[No Abstract] [Full Text] [Related]
11. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
12. ASO Author Reflections: Informing Patients About New Genetic Testing.
Romero Arenas MA; Grubbs EG
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):559-560. PubMed ID: 30617867
[No Abstract] [Full Text] [Related]
13. Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation.
Lahlou-Laforêt K; Consoli SM; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):354-8. PubMed ID: 22517555
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of phaeochromocytoma and paraganglioma.
Benn DE; Robinson BG
Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):435-50. PubMed ID: 16980204
[TBL] [Abstract][Full Text] [Related]
15. The genetic basis of pheochromocytoma and paraganglioma: implications for management.
Shuch B; Ricketts CJ; Metwalli AR; Pacak K; Linehan WM
Urology; 2014 Jun; 83(6):1225-32. PubMed ID: 24642075
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing in pheochromocytoma or functional paraganglioma.
Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
[TBL] [Abstract][Full Text] [Related]
17. A founder SDHB mutation in Portuguese paraganglioma patients.
Martins RG; Nunes JB; Máximo V; Soares P; Peixoto J; Catarino T; Rito T; Soares P; Pereira L; Sobrinho-Simões M; Santos AP; Couto J; Henrique R; Matos-Loureiro J; Dias P; Torres I; Lima J
Endocr Relat Cancer; 2013 Dec; 20(6):L23-6. PubMed ID: 24092654
[No Abstract] [Full Text] [Related]
18. Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: riding the new wave, but with caution.
Toledo RA; Dahia PL
Clin Endocrinol (Oxf); 2014 Jan; 80(1):23-4. PubMed ID: 24168015
[No Abstract] [Full Text] [Related]
19. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma and Paraganglioma Susceptibility Genes: Estimating the Associated Risk of Disease.
Fishbein L; Nathanson KL
JAMA Oncol; 2017 Sep; 3(9):1212-1213. PubMed ID: 28384677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
